Telomere length is a prognostic biomarker in elderly advanced ovarian cancer patients: a multicenter GINECO study-Reference-Cited by-同舟云学术

Telomere length is a prognostic biomarker in elderly advanced ovarian cancer patients: a multicenter GINECO study

Published:2015-12-03 Issue:12 Volume:7 Page:1066-1074
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Falandry Claire¹,Horard Béatrice²,Bruyas Amandine³,Legouffe Eric⁴,Cretin Jacques⁵,Meunier Jérôme⁶,Alexandre Jérôme⁷,Delecroix Valérie⁸,Fabbro Michel⁹,Certain Marie-Noëlle¹⁰,Maraval-Gaget Raymonde¹¹,Pujade-Lauraine Eric⁷,Gilson Eric¹²,Freyer Gilles¹³

Affiliation:

1. Geriatrics and Oncology Unit, HCL Cancer Institute, LBMC, CarMEN Laboratory, Lyon 1 University, Lyon, France

2. LBMC, ENS/Lyon, Lyon 1 University,CGphiMC Lyon 1 University, Lyon, France

3. Oncology Unit, Lyon Sud University Hospital, Lyon University, Pierre-Bénite, France

4. Clinique Valdegour, Department of Medical Oncology, Nîmes, France

5. Clinique Bonnefon, Oncology and Radiotherapy Department, Alès, France

6. Centre Hospitalier Régional d'Orléans, Department of Medical Oncology, Orléans, France

7. Paris Descartes University, AP-HP, Hôpitaux Universitaires Paris Centre, Site Hôtel Dieu, Paris, France

8. Clinique Mutualiste de l'Estuaire, Cité Sanitaire, Department of Medical Oncology, Saint-Nazaire, France

9. Institut du Cancer Montpellier, Medical Oncology, Montpellier, France

10. Centre Hospitalier d'Auxerre, Department of Medical Oncology, Auxerre, France

11. Lyon Sud University Hospital, Pierre-Bénite, France

12. LBMC, Lyon 1 University, IRCAN, CNRS UMR 7284, INSERM U1081, Nice Sophia-Antipolis University; CHU of Nice, Nice, France

13. HCL Cancer Institute, Department of Medical Oncology, Lyon 1 University, Lyon, France

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Telomere length as a predictor of therapy response and survival in patients diagnosed with ovarian carcinoma;Heliyon;2024-07

2. The association of blood biomarkers with treatment response and adverse health outcomes in older patients with solid tumors: A systematic review;Journal of Geriatric Oncology;2023-09

3. Role of telomere length in human carcinogenesis (Review);International Journal of Oncology;2023-05-22

4. Blood-based biomarkers of frailty in solid tumors: a systematic review;Frontiers in Public Health;2023-05-04

5. Impact of baseline telomere length on survival and chemotherapy related toxicity in breast cancer patients receiving (neo)adjuvant anthracycline containing chemotherapy;Translational Oncology;2022-12